Search research articles
Contact Us
Filters
Showing results (171-180 of 221) with videos related to
Page
of 23
Sort By:
British Journal of Haematology
|
June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations
Nicole Naumann, Johannes Lübke, William Shomali, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 19, 2020
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis
Juliana Schwaab, Nicole Cabral do O Hartmann, Nicole Naumann, et al.
Haematologica
|
September 6, 2015
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
Tariq I Mughal, Nicholas C P Cross, Eric Padron, et al.
Leukemia
|
October 7, 2021
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions
Elspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, et al.
Journal of Cancer Research and Clinical Oncology
|
February 23, 2017
Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis
Andreas Hochhaus, Franҫois-Xavier Mahon, Philipp le Coutre, et al.
Blood
|
August 21, 2013
Comprehensive mutational profiling in advanced systemic mastocytosis
Juliana Schwaab, Susanne Schnittger, Karl Sotlar, et al.
Blood
|
April 2, 2014
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib
Chan Y Cheah, Kate Burbury, Jane F Apperley, et al.
International Journal of Molecular Sciences
|
April 3, 2021
Adverse Prognostic Impact of the <i>KIT</i> D816V Transcriptional Activity in Advanced Systemic Mastocytosis
Nicole Naumann, Johannes Lübke, Sofie Baumann, et al.
Journal of Cancer Research and Clinical Oncology
|
April 2, 2017
Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis
Francis J Giles, Delphine Rea, Gianantonio Rosti, et al.
British Journal of Haematology
|
October 13, 2012
Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations
Anthony J Bench, Helen E White, Letizia Foroni, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 221) with videos related to
Sort By:
Page
of 23
British Journal of Haematology
|
June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations
Nicole Naumann, Johannes Lübke, William Shomali, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 19, 2020
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis
Juliana Schwaab, Nicole Cabral do O Hartmann, Nicole Naumann, et al.
Haematologica
|
September 6, 2015
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
Tariq I Mughal, Nicholas C P Cross, Eric Padron, et al.
Leukemia
|
October 7, 2021
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions
Elspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, et al.
Journal of Cancer Research and Clinical Oncology
|
February 23, 2017
Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis
Andreas Hochhaus, Franҫois-Xavier Mahon, Philipp le Coutre, et al.
Blood
|
August 21, 2013
Comprehensive mutational profiling in advanced systemic mastocytosis
Juliana Schwaab, Susanne Schnittger, Karl Sotlar, et al.
Blood
|
April 2, 2014
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib
Chan Y Cheah, Kate Burbury, Jane F Apperley, et al.
International Journal of Molecular Sciences
|
April 3, 2021
Adverse Prognostic Impact of the <i>KIT</i> D816V Transcriptional Activity in Advanced Systemic Mastocytosis
Nicole Naumann, Johannes Lübke, Sofie Baumann, et al.
Journal of Cancer Research and Clinical Oncology
|
April 2, 2017
Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis
Francis J Giles, Delphine Rea, Gianantonio Rosti, et al.
British Journal of Haematology
|
October 13, 2012
Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations
Anthony J Bench, Helen E White, Letizia Foroni, et al.
Page
of 23